Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
PinkStar Technologies is gearing up for a $3 million funding round to advance its AI-powered breast MRI platform aimed at improving cancer detection. This funding will support R&D, regulatory approvals, and market launch in the US.
PinkStar Technologies is developing an AI-powered decision support platform for breast MRI, designed to help radiologists detect breast cancer earlier. The upcoming $3 million funding will aid in completing R&D and obtaining FDA clearance. Additionally, it will enable team growth and preparation for the US market launch. The company aims to enhance the efficiency and accuracy of breast cancer detection.
Company Information
Company
PinkStar Technologies
Location
London, England, United Kingdom
About
PinkStar Technologies is developing an AI-powered decision support platform for breast MRI to assist radiologists in detecting breast cancer earlier and more confidently. Founded in collaboration with Sheba Medical Center, their technology aims to improve early detection and reduce missed findings, supporting more efficient workflows. The startup is currently advancing clinical validation and preparation for regulatory approval. With a dedicated team, PinkStar addresses unmet needs in women’s healthcare through innovative technology.
Don't miss PinkStar Technologies's next move
Get an email the moment PinkStar Technologies raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for PinkStar Technologies's next move